AMANDA DAY: Open Payments
NPI 1467099796 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,272 in 56 payments from 18 companies in 2025. Trend: 2023 $1,409 · 2024 $1,193 · 2025 $1,272
Food & beverage: $1,272
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $158 |
| Otsuka America Pharmaceutical, Inc. | 6 | $152 |
| Calliditas Therapeutics US Inc. | 6 | $142 |
| Travere Therapeutics, Inc. | 8 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $112 |
| Novartis Pharmaceuticals Corporation | 5 | $102 |
| Vifor Pharma, Inc. | 3 | $75 |
| GlaxoSmithKline, LLC. | 3 | $75 |
| KYOWA KIRIN, INC. | 2 | $54 |
| Amgen Inc. | 2 | $36 |
Products named: JYNARQUE, TARPEYO, JARDIANCE, FARXIGA, Fabhalta, Veltassa, CRYSVITA, SHINGRIX.
Industry payments across TX — which companies pay providers there.
